Filing Details

Accession Number:
0000711377-19-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-22 18:27:43
Reporting Period:
2019-05-13
Accepted Time:
2019-05-22 18:27:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-13 5,000 $60.73 671,484 No 4 S Direct
Common Stock Disposition 2019-05-20 10,000 $58.21 312,373 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect See Footnote
Footnotes
  1. These shares were sold pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 12, 2019
  2. Mr. Herbert's spouse sold 10,000 shares out of her trust; 94,880 shares remain in the trust. A total of 57,521 shares remain in a charitable remainder trust in which Mr. Herbert and his spouse are trustees and beneficiaries; the remainder of the shares are held in limited liability companies in which Mr. Herbert and his spouse hold minority financial positions.